Meeting
2016 ASCO Annual Meeting
Tumor response assessment by Choi criteria in localized high-risk soft tissue sarcoma (STS) treated with chemotherapy (CT): Update at 10-year follow-up of an exploratory analysis on a phase III trial.
Authors
Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Silvia Stacchiotti , Paolo Verderio , Antonella Messina , Carlo Morosi , Paola Collini , Antonio Llombart-Bosch , Javier Martin Broto , Alessandro Comandone , Josefina Cruz , Stefano Ferrari , Giovanni Grignani , Stefano Bottelli , Vittorio Quagliuolo , Piero Picci , Antonino De Paoli , Angelo Paolo Dei Tos , Paolo Giovanni Casali , Alessandro Gronchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
2004-003979-36
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11044)
DOI
10.1200/JCO.2016.34.15_suppl.11044
Abstract #
11044
Poster Bd #
170
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
First Author: S. Stacchiotti
Poster
2020 ASCO Virtual Scientific Program
Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS 1001).
First Author: Javier Martin Broto
First Author: Silvia Stacchiotti
Poster
2016 ASCO Annual Meeting
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): Long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
First Author: Elena Palassini